3,4 American Association of Clinical Endocrinology guidelines recommend treatment with GLP-1RA in T2DM patients with coexisting ASCVD, high-risk for ASCVD, heart failure, or chronic kidney disease regardless of their glycemic control due to their organ protective effects
May 2024 - At least 87 lawsuits have already been filed against drug manufacturers
Consistency: Taking your injection on the same day each week and maintaining consistent eating habits produces the best outcomes
Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, doubleblind, placebo and active controlled, doseranging, phase 2 trial
Adults with a body mass index of at least 27 kg/m2 and glycated hemoglobin levels between 7 and 10% who had been diagnosed with type 2 diabetes for at least 180 days prior to screening were included in the double-blind, double-dummy study